Darcy Ellen Hamill, DO
Hematology/OncologyInsurance Accepted
- Aetna Better Health PA Kids HMO
- Aetna HMO
- Aetna PPO/EPO/POS
- Aetna PPO/POS/EPO
- Amerihealth Caritas DE - PENNSYLVANIA SPECIALISTS ONLY
- Amerihealth Caritas Delaware
- Amerihealth Caritas Delaware NJ
- Carefirst MD Community Health Plan Mcaid
- Cigna & Great West HMO/POS/EPO
- Cigna & Great West PPO
- Cigna Lifesource Transplant
- Cigna/Great West HMO EPO POS
- Cigna/Great West PPO
- Delaware First Health
- Delaware Medicaid/Diamond State
- Delaware Medicare
- Devon Health Services
- Fidelis Care NJ Medicaid HMO
- First Health PPO
- First Health/Affordable PPO
- Geisinger Health Plan Commercial
- Global Medical Managment DE/PA
- Global Medical Mangment NJ
- Health Partners Medicaid/Kidz Partner HMO
- Highmark Blue Cross Blue Shield of Delaware
- Highmark Blue Cross Blue Shield of Pennsylvania
- Highmark Medicaid Health Options
- Horizon Blue Cross Blue Shield of New Jersey
- Independance Blue Cross/Amerihealth/Keystone Health Plan
- Insurance Administrators of America
- INTEGRA Administrative Group (ClaimsBridge)
- Keystone First Medicaid HMO
- Lifetrac Transplant
- Maryland Medicaid
- Multiplan PPO
- New Jersey Medicaid
- Olympus Managed Healthcare PPO DE/PA
- Pennsylvania Medicaid
- Plan Vista/NPPN PPO
- Preferred Healthcare PPO
- Private Health Care Systems (PHCS)
- Private Healthcare Systems (PHCS)
- Qualcare HMO/POS/PPO
- Star Healthcare Network
- Three Rivers Provider Network
- Tricare/Humana Military Health Services
- United Healthcare of the Mid-Atlantic
- UPMC MCAID/CHIP PA DE
- UPMC Medicaid
- US Family Health Plan
- Wellpoint Maryland Medcaid
- Blood and Bone Marrow Transplantation
- Cancer Care
- Leukemia
- Lymphoma
- Neuroblastoma
- Neutropenia
-
Gopalakrishnapillai, A., Correnti, C. E., Pilat, K., Lin, I., Chan, M. K., Bandaranayake, A. D., & Barwe, S. P. (2021). Immunotherapeutic targeting of mesothelin positive pediatric aml using bispecific t cell engaging antibodies. Cancers, 13(23). doi:10.3390/cancers13235964
-
Kinnaman, Hamill, D., Yabe, M., Powell, J., Benhamida, J., Hasselblatt, M., & Shukla, N. (2020). Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1. JCO Precision Oncology, 4, 1280-1284. doi:10.1200/PO.20.00215
- English